Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 6 of 1714:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Gene Compound Assay Inh Ic50 Ki View
5-hydroxytryptamine (serotonin) receptor 2A MICONAZOLE Serotonin 5-HT2A 100% 3.907uM 1.116uM View
Cytochrom P450-2C19 monooxygenase MICONAZOLE CYP450-2C19 Inhibition 100% .016uM NoneNone View
tachykinin receptor 1 MICONAZOLE Tachykinin NK1 100% 6.813uM 3.716uM View
opioid receptor, delta 1 MICONAZOLE Opiate delta 100% 3.387uM 1.194uM View
tachykinin receptor 2 ECONAZOLE Tachykinin NK2 100% 6.033uM 2.011uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 ECONAZOLE Dopamine Transporter 100% .835uM .663uM View
cholinergic receptor, muscarinic 1 ECONAZOLE Muscarinic M1 100% 2.642uM .636uM View
cholinergic receptor, muscarinic 4 ECONAZOLE Muscarinic M4 100% 2.122uM .296uM View
opioid receptor, kappa 1 ECONAZOLE Opiate kappa 100% 8.616uM 3.446uM View
mu-opioid receptor MOR ECONAZOLE Opiate mu 100% 5.693uM 2.311uM View
adrenergic receptor, alpha 2b ECONAZOLE Adrenergic alpha2B 100% 5.863uM 2.677uM View
dopamine receptor D3 ECONAZOLE Dopamine D3 100% 4.756uM 1.615uM View
tachykinin receptor 1 ECONAZOLE Tachykinin NK1 100% 11.87uM 6.476uM View
dopamine receptor D1A ECONAZOLE Dopamine D1 100% 9.225uM 4.612uM View
dopamine receptor D4 ECONAZOLE Dopamine D4.2 100% 9.328uM 3.271uM View
cholinergic receptor, muscarinic 3 ECONAZOLE Muscarinic M3 100% 1.789uM .379uM View
opioid receptor, delta 1 ECONAZOLE Opiate delta 100% 1.442uM .508uM View
sodium channel, voltage-gated, type IV, beta ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel associated protein 1 ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel associated protein 2 ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type III, beta ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type I, alpha ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type IX, alpha ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type VII, alpha ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
amiloride-sensitive cation channel 5, intestinal ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type III, beta ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type XI, alpha ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type I, beta ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type 10, alpha polypeptide ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type IV, alpha polypeptide ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type V, alpha polypeptide ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type II, beta ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, nonvoltage-gated 1 alpha ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, nonvoltage-gated 1 gamma ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, nonvoltage-gated 1 beta ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type XI, alpha ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, nonvoltage-gated 1, gamma ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, nonvoltage-gated 1, delta ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, nonvoltage-gated 1 alpha ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type X, alpha ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type IX, alpha ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage gated, type VIII, alpha ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type VII, alpha ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type IV, beta ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type IV, alpha ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type III, alpha ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type II, beta ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type II, alpha 2 ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type I, beta ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
sodium channel, voltage-gated, type I, alpha ECONAZOLE Sodium Channel, Site 2 100% 3.467uM 3.108uM View
carbonic anhydrase 4 ACETAZOLAMIDE Carbonic Anhydrase 100% .101uM NoneNone View
carbonic anhydrase XI ACETAZOLAMIDE Carbonic Anhydrase 100% .101uM NoneNone View
carbonic anhydrase IX ACETAZOLAMIDE Carbonic Anhydrase 100% .101uM NoneNone View
carbonic anhydrase VIII ACETAZOLAMIDE Carbonic Anhydrase 100% .101uM NoneNone View
carbonic anhydrase VII ACETAZOLAMIDE Carbonic Anhydrase 100% .101uM NoneNone View
carbonic anhydrase VA, mitochondrial ACETAZOLAMIDE Carbonic Anhydrase 100% .101uM NoneNone View
carbonic anhydrase IV ACETAZOLAMIDE Carbonic Anhydrase 100% .101uM NoneNone View
carbonic anhydrase III, muscle specific ACETAZOLAMIDE Carbonic Anhydrase 100% .101uM NoneNone View
carbonic anhydrase I ACETAZOLAMIDE Carbonic Anhydrase 100% .101uM NoneNone View
carbonic anhydrase XIV ACETAZOLAMIDE Carbonic Anhydrase 100% .101uM NoneNone View
carbonic anhydrase VB, mitochondrial ACETAZOLAMIDE Carbonic Anhydrase 100% .101uM NoneNone View
carbonic anhydrase XII ACETAZOLAMIDE Carbonic Anhydrase 100% .101uM NoneNone View
carbonic anhydrase VI ACETAZOLAMIDE Carbonic Anhydrase 100% .101uM NoneNone View
carbonic anhydrase II ACETAZOLAMIDE Carbonic Anhydrase 100% .101uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 DEXCHLORPHENIRAMINE Serotonin Transporter 100% .025uM .013uM View
adrenergic receptor, alpha 2b ERGOCORNINE Adrenergic alpha2B 100% .003058uM .001396uM View
5-hydroxytryptamine (serotonin) receptor 2B ERGOCORNINE Serotonin 5-HT2B 100% .011uM .006855uM View
5-hydroxytryptamine (serotonin) receptor 1B ERGOCORNINE Serotonin 5-HT1B 100% .03uM .019uM View
tachykinin receptor 2 CIGLITAZONE Tachykinin NK2 100% 12.576uM 4.192uM View
adrenergic receptor, alpha 1a ERGOCORNINE Adrenergic alpha1A 100% .011uM .004472uM View
adrenergic receptor, alpha 1b ERGOCORNINE Adrenergic alpha1B 100% .00519uM .002873uM View
dopamine receptor D3 ERGOCORNINE Dopamine D3 100% .00286uM .000971uM View
5-hydroxytryptamine (serotonin) receptor 1A ERGOCORNINE Serotonin 5-HT1A 100% .003107uM .001775uM View
5-hydroxytryptamine (serotonin) receptor 2C ERGOCORNINE Serotonin 5-HT2C 100% .104uM .055uM View
5-hydroxytryptamine receptor 6 ERGOCORNINE Serotonin 5-HT6 100% .015uM .007093uM View
histamine receptor H 1 AMOXAPINE Histamine H1, Central 100% .099uM .011uM View
5-hydroxytryptamine (serotonin) receptor 2A AMOXAPINE Serotonin 5-HT2A 100% .001552uM .000444uM View
5-hydroxytryptamine receptor 6 AMOXAPINE Serotonin 5-HT6 100% .076uM .035uM View
adrenergic receptor, alpha 1b AMOXAPINE Adrenergic alpha1B 100% .109uM .06uM View
dopamine receptor D3 AMOXAPINE Dopamine D3 100% .134uM .046uM View
adrenergic receptor, alpha 2b AMITRIPTYLINE Adrenergic alpha2B 100% .008076uM .003687uM View
dopamine receptor D3 AMITRIPTYLINE Dopamine D3 100% .182uM .062uM View
histamine receptor H 1 AMITRIPTYLINE Histamine H1, Central 100% .004782uM .000555uM View
adrenergic receptor, alpha 1b AMITRIPTYLINE Adrenergic alpha1B 100% .076uM .042uM View
histamine receptor H 2 AMITRIPTYLINE Histamine H2 100% .73uM .718uM View
cholinergic receptor, muscarinic 5 AMITRIPTYLINE Muscarinic M5 100% .00802uM .005762uM View
5-hydroxytryptamine (serotonin) receptor 2A AMITRIPTYLINE Serotonin 5-HT2A 100% .015uM .004374uM View
5-hydroxytryptamine (serotonin) receptor 2C AMITRIPTYLINE Serotonin 5-HT2C 100% .006048uM .003168uM View
5-hydroxytryptamine receptor 6 AMITRIPTYLINE Serotonin 5-HT6 100% .14uM .065uM View
tachykinin receptor 2 PACLITAXEL Tachykinin NK2 100% 6.125uM 2.042uM View
arachidonate 15-lipoxygenase, second type RIFAMPIN Lipoxygenase 15-LO 100% 2.949uM NoneNone View
arachidonate 15-lipoxygenase RIFAMPIN Lipoxygenase 15-LO 100% 2.949uM NoneNone View
arachidonate 15-lipoxygenase RIFAMPIN Lipoxygenase 15-LO 100% 2.949uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) DOXORUBICIN Protein Tyrosine Kinase, HER2 Receptor 100% 2.485uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) DOXORUBICIN Protein Tyrosine Kinase, HER2 Receptor 100% 2.485uM NoneNone View
nuclear receptor subfamily 3, group C, member 1 DEXAMETHASONE Glucocorticoid 100% .00806uM .003664uM View
Cytochrom P450-1A2 monooxygenase BENZO[E]PYRENE CYP450-1A2 Inhibition 100% .1uM NoneNone View
Cytochrom P450-1A2 monooxygenase 6(5H)-PHENANTHRIDINONE CYP450-1A2 Inhibition 100% .016uM NoneNone View
opioid receptor, delta 1 NALOXONAZINE Opiate delta 100% .136uM .048uM View
opioid receptor, kappa 1 NALOXONAZINE Opiate kappa 100% .085uM .034uM View
mu-opioid receptor MOR NALOXONAZINE Opiate mu 100% .007196uM .002921uM View
sodium channel, voltage-gated, type IV, beta TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel associated protein 1 TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel associated protein 2 TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type III, beta TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type I, alpha TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type IX, alpha TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type VII, alpha TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
amiloride-sensitive cation channel 5, intestinal TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type III, beta TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type XI, alpha TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type I, beta TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type 10, alpha polypeptide TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type IV, alpha polypeptide TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type III, beta CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type I, alpha CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type IX, alpha CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type VII, alpha CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
amiloride-sensitive cation channel 5, intestinal CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type III, beta CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type XI, alpha CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type I, beta CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type 10, alpha polypeptide CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type IV, alpha polypeptide CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type V, alpha polypeptide CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type II, beta CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, nonvoltage-gated 1 alpha CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, nonvoltage-gated 1 gamma CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, nonvoltage-gated 1 beta CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type XI, alpha CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, nonvoltage-gated 1, gamma CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, nonvoltage-gated 1, delta CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, nonvoltage-gated 1 alpha CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type X, alpha CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type IX, alpha CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage gated, type VIII, alpha CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type VII, alpha CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type IV, beta CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type IV, alpha CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type III, alpha CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type II, beta CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type II, alpha 2 CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type I, beta CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel, voltage-gated, type I, alpha CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
histamine receptor H 1 CHLORPROMAZINE Histamine H1, Central 100% .017uM .001957uM View
dopamine receptor D3 CLOTRIMAZOLE Dopamine D3 100% 2.647uM .899uM View
mu-opioid receptor MOR CLOTRIMAZOLE Opiate mu 100% 1.802uM .731uM View
5-hydroxytryptamine (serotonin) receptor 2A CLOTRIMAZOLE Serotonin 5-HT2A 100% 11.142uM 3.183uM View
histamine receptor H 2 CHLORPROMAZINE Histamine H2 100% 2.626uM 2.582uM View
tachykinin receptor 2 CLOTRIMAZOLE Tachykinin NK2 100% 10.15uM 3.383uM View
arachidonate 15-lipoxygenase, second type TANNIC ACID Lipoxygenase 15-LO 100% .268uM NoneNone View
arachidonate 15-lipoxygenase TANNIC ACID Lipoxygenase 15-LO 100% .268uM NoneNone View
arachidonate 15-lipoxygenase TANNIC ACID Lipoxygenase 15-LO 100% .268uM NoneNone View
sodium channel, voltage-gated, type IV, beta U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel associated protein 1 U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel associated protein 2 U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type III, beta U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type I, alpha U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type IX, alpha U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type VII, alpha U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
amiloride-sensitive cation channel 5, intestinal U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type III, beta U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type XI, alpha U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type I, beta U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type 10, alpha polypeptide U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type IV, alpha polypeptide U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type V, alpha polypeptide U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type II, beta U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, nonvoltage-gated 1 alpha U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, nonvoltage-gated 1 gamma U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, nonvoltage-gated 1 beta U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type XI, alpha U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
adrenergic receptor, alpha 2b TERAZOSIN Adrenergic alpha2B 100% .428uM .195uM View
glutamate receptor, ionotropic, AMPA1 (alpha 1) (RS)-AMPA Glutamate, AMPA 100% .024uM .019uM View
glutamate receptor, ionotropic, AMPA2 (RS)-AMPA Glutamate, AMPA 100% .024uM .019uM View
glutamate receptor, ionotropic, AMPA3 (alpha 3) (RS)-AMPA Glutamate, AMPA 100% .024uM .019uM View
glutamate receptor subunit 4c (RS)-AMPA Glutamate, AMPA 100% .024uM .019uM View
nuclear receptor subfamily 3, group C, member 1 BETAMETHASONE PHOSPHATE Glucocorticoid 100% .008216uM .003734uM View
sodium channel, voltage-gated, type IV, beta CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel associated protein 1 CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
sodium channel associated protein 2 CHLORPROMAZINE Sodium Channel, Site 2 100% 2.832uM 2.539uM View
progesterone receptor DIFLORASONE DIACETATE Progesterone 100% .116uM .015uM View
progesterone receptor DIFLORASONE DIACETATE Progesterone 100% .116uM .015uM View
cholinergic receptor, muscarinic 3 DICYCLOMINE Muscarinic M3 100% .004375uM .000927uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 TAMOXIFEN Serotonin Transporter 100% 2.334uM 1.24uM View
adrenergic receptor, alpha 2a BRIMONIDINE Imidazoline I2, Central 100% .074uM .049uM View
adrenergic receptor, alpha 2c (Non-specific probe) BRIMONIDINE Imidazoline I2, Central 100% .074uM .049uM View
adrenergic receptor, alpha 1b DIHYDROERGOTAMINE Adrenergic alpha1B 100% .008088uM .004477uM View
dopamine receptor D3 DIHYDROERGOTAMINE Dopamine D3 100% .005336uM .001812uM View